Study on Clostridium Difficile Infection in Infants

ConditionClostridium Difficile Infection

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-24

SponsorFirst People's Hospital of Hangzhou

About this trial

This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.

Eligibility criteria

Qualifiers

Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group).

Disqualifiers

Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.

Trial design

Treatments tested in this trial

Not listed

Trial groups

150 Participants

are grouped into 2 trial groups

Sponsors and collaborators

First People's Hospital of Hangzhou

Lead sponsor

Westlake University

Collaborator

Source ClinicalTrials.gov